NCI Data Jamboree (Project Abstract Submission): Submission #19

Submission information
Submission Number: 19
Submission ID: 186660
Submission UUID: 33ff26ab-39bc-4ca9-904f-5452695e4649

Created: Wed, 07/15/2026 - 12:10
Completed: Wed, 07/15/2026 - 14:14
Changed: Wed, 07/15/2026 - 14:14

Remote IP address: 10.208.24.175
Submitted by: Anonymous
Language: English

Is draft: No
First Name Hongyi
Middle Initial
Last Name Liu
Degree(s) Ph.D.
Position/Title/Career Status
Organization Johns Hopkins University
Organization Address Baltimore
Email hliu173@jh.edu
List of Additional Authors
  • First Name: Yingwei
    Last Name: Hu
    Affiliation: Johns Hopkins University
  • First Name: Mamie
    Last Name: Lih
    Affiliation: Johns Hopkins University
  • First Name: Effram
    Last Name: Wei
    Affiliation: Johns Hopkins University
  • First Name: Liyuan
    Last Name: Jiao
    Affiliation: Johns Hopkins University
  • First Name: Lijun
    Last Name: Chen
    Affiliation: Johns Hopkins University
  • First Name: Yuefan
    Last Name: Wang
    Affiliation: Johns Hopkins University
  • First Name: Xiangning
    Last Name: Li
    Affiliation: Johns Hopkins University
  • First Name: Zhenyu
    Last Name: Sun
    Affiliation: Johns Hopkins University
  • First Name: Yuanyu
    Last Name: Huang
    Affiliation: Johns Hopkins University
  • First Name: Yuanwei
    Last Name: Xu
    Affiliation: Johns Hopkins University
  • First Name: Hui
    Last Name: Zhang
    Affiliation: Johns Hopkins University
Abstract Category Employing statistical, computational, and informatics tools, algorithms, and methods to integrate or analyze data
Abstract Keywords Prostate cancer, proteomics, glycoproteomics, phosphoproteomics, crosstalk
Abstract Title Unlocks the Biological Insights into Aggressive Prostate Cancer Using Multi-omic Approach
Abstract Scientific Questions: This project integrates large-scale multi-omics to address: (1) how multi-layer genomics, proteomics (TMT/DIA), and post-translational modifications (PTMs) correlate globally; (2) how to digitally deconvolve tumor microenvironment (TME) cell fractions; and (3) how to map the causal directional regulatory cascades between cell-surface glycosylation and intracellular phosphorylation to identify therapeutic targets.
Community Significance: Prostate cancer has profound molecular heterogeneity. Providing a reproducible, open-source computational framework for integrating mass-spectrometry-based proteomics and dual-PTM networks allows the broader cancer research community to uncover targetable biological pathways and patient subclusters obscured in genomic-only studies.
Datasets & Tools: We leverage clinical cohorts (244 samples) with comprehensive transcriptomics, global proteomics (TMT/DIA), and deeply enriched PTMs (phospho, intact glycopeptide, ubiquitin, p-Tyr, acetyl). Key informatics tools include xCell/CIBERSORTx for cellular deconvolution, Random Forest and Lasso-logistic regression for tumor grading classifiers (NAT vs. Low/High Gleason grades), human interactome mapping for protein-protein interaction (PPI) topology, and Bayesian modeling for causal dual-PTM network inference.